医療用酸素濃縮器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の医療用酸素濃縮器の市場規模は、予測期間（2024年～2030年）にCAGRで5.63％の成長が見込まれます。医療用酸素濃縮器需要の増加は主に、慢性閉塞性肺疾患（COPD）、睡眠時無呼吸症候群、低酸素血症、肺水腫などの呼吸器疾患の有病率の増加、高齢患者や寝たきりの患者における需要のさらなる増加、世界のCOVID-19パンデミック後の医療用酸素濃縮器需要の急増によるもので、これらの要因が市場を強化すると予測されており、2024年～2030年の予測期間における医療用酸素濃縮器市場の成長に寄与しています。

医療用酸素濃縮器の市場力学

製品需要の主な要因は、慢性閉塞性肺疾患（COPD）、睡眠時無呼吸症候群、低酸素血症、肺水腫などの呼吸器疾患の有病率の増加、老人や寝たきり患者の有病率の増加です。

世界保健機関（WHO）（2022）によると、慢性閉塞性肺疾患（COPD）は世界第3位の死因となっています。COPDでは酸素濃度の低下を抑制するために酸素療法が必要であり、COPDの有病率の増加は酸素濃縮器の需要を増加させます。Burden of Obstructive Lung Disease（BOLD）レポートによると、2020年、COPDが原因で年間300万人近くが死亡しています。また同資料によると、COPDは今後40年間で増加すると予測され、2060年までにCOPDが原因で年間540万人以上が死亡する可能性があります。COPDは喫煙率の増加とともに増加します。米国疾病予防管理センター（Centers for Disease Control and Prevention）によると、2020年に18歳以上の米国成人の100人中13人近く（12.5％）がタバコを吸っています。米国では現在、推定3,080万人の成人がタバコを吸っており、1,600万人以上の米国人が喫煙に関連した疾患を抱えています。この喫煙率の増加はCOPDの有病率を押し上げ、酸素濃縮器市場にプラスの影響を与えます。

さらに、Forum of International Respiratory Societiesが発表したGlobal Impact of Respiratory Disease report（第3版、2022）によると、2019年に1億人以上が睡眠呼吸障害に苦しんでいます。睡眠時無呼吸症候群のような睡眠障害では、酸素濃度をコントロールするために酸素療法が行われますが、これが医療用酸素濃縮器の需要をさらに高めると予測されます。ストレスの多いライフスタイルも、2024年～2030年の予測期間に若年層の睡眠障害の増加に寄与します。

室内の空気汚染物質の増加や喫煙者の増加も、医療用酸素濃縮器市場の成長促進要因となっています。空気汚染にさらされる機会が増えると、呼吸器系の疾患を引き起こす可能性があります。American Lung Associationによると、2022年に米国人の10人に4人以上は空気質がよくない場所に住んでいます。同資料によると、2022年の「State of the Air」でオゾンか粒子状物質汚染のどちらかがFの評価を受けた郡には、1億3,500万人以上が住んでいます。

また、多数の高齢患者や寝たきりの患者も、医療用酸素濃縮器が使用される要因の1つです。Global Initiative for Chronic Obstructive Lung Disease（2020）のレポートによると、COPDの有病率は年齢とともに急上昇し、60歳以上の有病率がもっとも高くなっています。呼吸器系は加齢とともに弱くなり、体内の酸素濃度が低下します。

息切れとして知られる呼吸困難は高齢者に多く、65歳以上の約30％に認められます。呼吸困難は主要な兆候と考えられており、医療用酸素濃縮器はこの症状を治療するために提供され、医療機器の市場成長を増大させます。

当レポートでは、世界の医療用酸素濃縮器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 医療用酸素濃縮器市場レポートのイントロダクション

第2章 医療用酸素濃縮器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 医療用酸素濃縮器市場の主な要因の分析

• 医療用酸素濃縮器市場の促進要因
  • 高齢患者や寝たきりの患者向けの医療用酸素濃縮器のニーズの増加
  • 呼吸器疾患の有病率の増加
  • COVID-19パンデミックにおける酸素濃縮器の予期せぬ需要
• 医療用酸素濃縮器市場の抑制要因と課題
  • 厳格な規制当局の承認
  • 高いコスト
• 医療用酸素濃縮器市場の機会
  • 携帯式酸素濃縮器の需要の増加
  • 流量のカスタマイズ

第5章 医療用酸素濃縮器市場のポーターのファイブフォース分析

第6章 医療用酸素濃縮器市場に対するCOVID-19の影響分析

第7章 医療用酸素濃縮器の市場レイアウト

• 製品別
  • 固定式
  • 携帯式
• 技術別
  • 連続フロー
  • パルスフロー
  • 両方
• エンドユーザー別
  • 在宅ケア
  • 病院、診療所
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 医療用酸素濃縮器市場：世界の企業シェア分析 - 主要3～5社

第9章 医療用酸素濃縮器市場の企業と製品のプロファイル

• Koninklijke Philips N.V.
• Invacare Corporation
• DeVilbiss Healthcare LLC
• Inogen, Inc.
• Nidek Medical India
• O2 Concepts
• Teijin Aramid B.V
• Supera Anesthesia Innovations
• GCE Group
• CAIRE Inc.
• OxyGo
• Precision medical, Inc.
• GF HEALTH PRODUCTS, INC.
• Belluscura
• Besco
• OSI - Oxygen Solutions Inc
• NGK Spark Plug Co Ltd
• Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)
• Narang Medical Limited
• Topson

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Medical Oxygen Concentrators Market in Global (2021-2030)
• Table 4: Medical Oxygen Concentrators Market in Global by Product (2021-2030)
• Table 5: Medical Oxygen Concentrators Market in Global by Technology (2021-2030)
• Table 6: Medical Oxygen Concentrators Market in Global by End User (2021-2030)
• Table 7: Medical Oxygen Concentrators Market in Global by Geography (2021-2030)
• Table 8: Medical Oxygen Concentrators Market in North America (2021-2030)
• Table 9: Medical Oxygen Concentrators Market in North America by Country (2021-2030)
• Table 10: Medical Oxygen Concentrators Market in the US (2021-2030)
• Table 11: Medical Oxygen Concentrators Market in Canada (2021-2030)
• Table 12: Medical Oxygen Concentrators Market in Mexico (2021-2030)
• Table 13: Medical Oxygen Concentrators Market in Europe (2021-2030)
• Table 14: Medical Oxygen Concentrators Market in Europe by Country (2021-2030)
• Table 15: Medical Oxygen Concentrators Market in France (2021-2030)
• Table 16: Medical Oxygen Concentrators Market in Germany (2021-2030)
• Table 17: Medical Oxygen Concentrators Market in the United Kingdom (2021-2030)
• Table 18: Medical Oxygen Concentrators Market in Italy (2021-2030)
• Table 19: Medical Oxygen Concentrators Market in Spain (2021-2030)
• Table 20: Medical Oxygen Concentrators Market in Russia (2021-2030)
• Table 21: Medical Oxygen Concentrators Market in Rest of Europe (2021-2030)
• Table 22: Medical Oxygen Concentrators Market in APAC (2021-2030)
• Table 23: Medical Oxygen Concentrators Market in APAC by Country (2021-2030)
• Table 24: Medical Oxygen Concentrators Market in China (2021-2030)
• Table 25: Medical Oxygen Concentrators Market in Japan (2021-2030)
• Table 26: Medical Oxygen Concentrators Market in India (2021-2030)
• Table 27: Medical Oxygen Concentrators Market in Australia (2021-2030)
• Table 28: Medical Oxygen Concentrators Market in South Korea (2021-2030)
• Table 29: Medical Oxygen Concentrators Market in Rest of APAC (2021-2030)
• Table 30: Medical Oxygen Concentrators Market in Rest of World (2021-2030)
• Table 31: Medical Oxygen Concentrators Market in RoW by Region (2021-2030)
• Table 32: Medical Oxygen Concentrators Market in Middle East (2021-2030)
• Table 33: Medical Oxygen Concentrators Market in Africa (2021-2030)
• Table 34: Medical Oxygen Concentrators Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Medical Oxygen Concentrators Market in Global (2021-2030)
• Figure 4: Medical Oxygen Concentrators Market in Global by Product (2021-2030)
• Figure 5: Medical Oxygen Concentrators Market in Global by Technology (2021-2030)
• Figure 6: Medical Oxygen Concentrators Market in Global by End User (2021-2030)
• Figure 7: Medical Oxygen Concentrators Market in Global by Geography (2021-2030)
• Figure 8: Medical Oxygen Concentrators Market in North America (2021-2030)
• Figure 9: Medical Oxygen Concentrators Market in North America by Country (2021-2030)
• Figure 10: Medical Oxygen Concentrators Market in the US (2021-2030)
• Figure 11: Medical Oxygen Concentrators Market in Canada (2021-2030)
• Figure 12: Medical Oxygen Concentrators Market in Mexico (2021-2030)
• Figure 13: Medical Oxygen Concentrators Market in Europe (2021-2030)
• Figure 14: Medical Oxygen Concentrators Market in Europe by Country (2021-2030)
• Figure 15: Medical Oxygen Concentrators Market in France (2021-2030)
• Figure 16: Medical Oxygen Concentrators Market in Germany (2021-2030)
• Figure 17: Medical Oxygen Concentrators Market in the United Kingdom (2021-2030)
• Figure 18: Medical Oxygen Concentrators Market in Italy (2021-2030)
• Figure 19: Medical Oxygen Concentrators Market in Spain (2021-2030)
• Figure 20: Medical Oxygen Concentrators Market in Russia (2021-2030)
• Figure 21: Medical Oxygen Concentrators Market in Rest of Europe (2021-2030)
• Figure 22: Medical Oxygen Concentrators Market in APAC (2021-2030)
• Figure 23: Medical Oxygen Concentrators Market in APAC by Country (2021-2030)
• Figure 24: Medical Oxygen Concentrators Market in China (2021-2030)
• Figure 25: Medical Oxygen Concentrators Market in Japan (2021-2030)
• Figure 26: Medical Oxygen Concentrators Market in India (2021-2030)
• Figure 27: Medical Oxygen Concentrators Market in Australia (2021-2030)
• Figure 28: Medical Oxygen Concentrators Market in South Korea (2021-2030)
• Figure 29: Medical Oxygen Concentrators Market in Rest of APAC (2021-2030)
• Figure 30: Medical Oxygen Concentrators Market in Rest of World (2021-2030)
• Figure 31: Medical Oxygen Concentrators Market in RoW by Region (2021-2030)
• Figure 32: Medical Oxygen Concentrators Market in Middle East (2021-2030)
• Figure 33: Medical Oxygen Concentrators Market in Africa (2021-2030)
• Figure 34: Medical Oxygen Concentrators Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Medical Oxygen Concentrators Market By Product (Stationary, Portable), By Technology (Continuous Flow, Pulse Flow, Both), By End-User (Homecare, Hospitals And Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increased prevelence of respiratory disorders like chornic obstructive pulmonary disease (COPD) and increased need for medical oxygen concentrators for geriatrics and bedridden patients

The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2024-2030). The increase in demand for Medical Oxygen Concentrators is primarily attributed to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness, further increased demand in geriatric and bedridden patients, and steep rise in demand of medical oxygen concentrators after COVID-19 pandemic across the world are anticipated to bolster the market, thereby contributing to the growth of the Medical Oxygen Concentrators market during the forecast period from 2024-2030.

Medical Oxygen Concentrators Market Dynamics:

The major factors responsible for product demand is increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased prevalence of geriatric and bedridden patients.

According to World Health Organization (WHO) 2022, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. Oxygen therapy is needed for COPD to control the oxygen level drops, increasing prevalence of COPD will increase the demand for oxygen concentrators. According to Burden of Obstructive Lung Disease (BOLD) report, 2020, there are nearly three million deaths annually due to COPD. Also as per the same source, COPD is expected to rise over the next 40 years and by 2060 there may be more than 5.4 million deaths annually due to COPD. COPD is increased with increased prevalence of smoking. As per Centers for Disease Control and Prevention, in 2020, nearly 13 of every 100 U.S. adults aged 18 years or older (12.5%) smoked cigarettes. An estimated 30.8 million adults in the United States currently smoke cigarettes and more than 16 million Americans live with a smoking-related disease. This increasing prevalence of smoking shoot up the prevalence of COPD, effecting the market of oxygen concentrators positively.

Moreover, according to the Global Impact of Respiratory Disease report (third edition, published in 2022) published by Forum of International Respiratory Societies, in 2019 more than 100 million people suffer from sleep-disordered breathing. During sleep-disorders like sleep-apnea oxygen therapy is provided to control the oxygen level, which is further expected to increase the demand for medical oxygen concentrators. Stressful lifestyle will also contribute to increase the sleep disorders in young age population during the forecasting period from 2024-2030.

Increase in indoor air pollutants as well as increase in pollution of active smokers, is also responsible for propelling the growth of the medical oxygen concentrator market. The increased exposure to air pollution can cause respiratory ailments in people. According the American Lung Association, 2022 more than four in ten Americans live where the air quality is not good. As per the same source, more than 135 million people live in counties that received an F for either ozone or particle pollution in "State of the Air" 2022.

Also, the prevalence of geriatric and bedridden patients is another factor responsible for the use of these Medical Oxygen Concentrators. According to the Global Initiative for Chronic Obstructive Lung Disease 2020 report, the prevalence of COPD increased steeply with age, with the highest prevalence among those with more than 60 years age. The respiratory system becomes weak with age, lowering the oxygen level in the body.

Dyspnea also known as shortness of breath is highly prevalent in the elderly, and is reported by approximately 30% of individuals greater than 65 years of age. In dyspnea difficulty in breathing is observed as a major symptom, medical oxygen concentrators can be provided to cure this symptom; increasing the market growth of the medical device.

Moreover, according to WHO 2022 report, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22% and by 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Furthermore, there was more need for oxygen concentrators during COVID-19 infection. During second wave of COVID-19 people purchased oxygen concentrators fearing the shortage of medical oxygen. Moreover, people with COVID-19 were at increased risk for pneumonia and hypoxemia, which are major predictor of mortality. People with these complications were recommended proper oxygen supply. This supply can be given by medical oxygen concentrators. This increased the demand of medical oxygen concentrators in the market. The rise in demand had led to hike in prices.

But, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemic made the resumption of regular healthcare services, which will keep a steady demand for these products on course in the Medical Oxygen Concentrators market.

Therefore, with proper monitoring and care the mortality and hospitalization due to respiratory ailment can be prevented. Hence, the growth of the Medical Oxygen Concentrators Market is expected to rise during the forecast period from 2024 to 2030.

However, the stringent regulatory process and high cost of devices may be certain limiting factors of the Medical Oxygen Concentrators market growth.

Medical Oxygen Concentrators Market Segment Analysis:

Medical oxygen concentrators market by product (stationary, portable), by technology (continuous flow, pulse flow, both), by end-user (homecare, hospitals and clinics, others) and by geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Technology segment of the Medical Oxygen Concentrators market, the Pulse Flow segment is estimated to hold a significant market share in the year 2023. This can be ascribed to the various advantages that are associated with the pulse flow oxygen concentrators.

Pulse flow oxygen concentrators puffs oxygen into the nasal passageway, through a cannula, with each breath. In these concentrators oxygen is delivered only during inhalation and is stored during exhalation thereby saving the amount of oxygen as well as life of battery used to operate the concentrators. This is useful when the patient is doing some other activity like drinking water. These device are mostly used by the patient in daytime as compared to nighttime because the breathing rate is not steady while sleeping.

Furthermore, advantageous properties such as more energy efficiency due to rest period between two breaths, increase in battery life due to rest period and smaller size. As well, doctors' advice pulse flow oxygen concentrators in moderate to severe respiratory ailments, where these devices are effectively used.

Moreover, various new products are coming into the market which in turn depicts the high demand of these products. For instance, In March 2022, Belluscura announced that the X-PLO2R pulse flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). X-PLO2R is a compact, quiet, weighing only 3.25 pounds, compact and portable oxygen concentrators.

Therefore, the advantages offered by the Pulse Flow in Medical Oxygen Concentrators are predicted to contribute to the increasing demand, thereby driving the growth of the overall Medical Oxygen Concentrators market during the forecast period.

North America is expected to dominate the overall Medical Oxygen Concentrators Market:

Among all the regions, North America is expected to account for the largest share in the global Medical Oxygen Concentrators market in the year 2023. Factors such as the growing prevalence of various respiratory ailments like COPD, hypoxia and others, increasing prevalence of geriatric and bedridden patients, increase in air pollution and smoking are some of the key factors which are expected to aid in the growth of North America Medical Oxygen Concentrators Market.

For instance, according to the WHO 2022, (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. The mortality rate can be reduced by giving emergency aid to serious patients by the providing medical oxygen concentrators to the patient, increasing the demand of device in the market.

Furthermore, as per the Centers for Disease Control and Prevention (CDC) 2022, COPD makes breathing difficult for the 16 million Americans. The difficulty in breathing can be managed by providing the medical oxygen concentrators to the patients thereby driving the market in North America.

Additionally, according to the Pan American Health Organization (PAHO), in 2019, the chronic respiratory disease accounts for 534,242 deaths in both sexes, 267,516 (50%) deaths in men and 266,725 (50%) in women. The increase in prevalence of chronic respiratory disease and deaths caused by them can be controlled by providing the patients with medical devices like oxygen concentrators and educating them about the usage of the device, will affect the market of the medical device positively.

Moreover, according to CDC, in 2020, preterm birth affected 1 of every 10 infants born in the United States. In preterm birth, organs like lungs, heart, and brain may not be fully developed. If the lungs are not developed properly then external source is used to provide oxygen to the baby. Medical oxygen concentrators can be used to provide oxygen in the above case. The prevalence is expected to rise at a significant rate in the forecast period. Thus, the burgeoning cases of premature births will contribute to the growth of the Medical Oxygen Concentrators market.

Furthermore, the government of the North America is actively involved in relevant organizations which can provide proper COPD management guidance to the patients. National Center for Immunization and Respiratory Diseases is under a mission to prevent the disease, disability, and death through immunization and to control of respiratory and related diseases. As the awareness of treatment and management of COPD will increase in the patient, use of oxygen concentrators will also increases in the market, thereby fostering the market in North America.

Therefore, the rising prevalence of these respiratory disorders in the North America would result in the rising demand for treatments that make use of Medical Oxygen Concentrators, which in turn would provide a conducive growth environment for the Medical Oxygen Concentrators market in the North American region.

Hence, the interplay of various factors such as the presence of a large respiratory ailment patient population, increased prevalence of preterm births in the region as well as awareness created among the patients by government and organizations is expected to boost the North America Medical Oxygen Concentrators market during the forecast period.

Medical Oxygen Concentrators Market Key Players:

Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical, O2 Concepts, Teijin Limited, Supera Anesthesia Innovations, GCE Group, CAIRE, OxyGo, LLC, Precision medical, Inc., Graham Field, Belluscura , Besco Medical Limited, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.

Recent Developmental Activities in the Medical Oxygen Concentrators Market:

In March 2022, Belluscura have signed a three-year manufacturing agreement for its X-PLO2r portable oxygen concentrator with InnoMax Medical Technology in China.

In March 2022, Belluscura announced that the X-PLO2R pulse-flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA).

In March 2022, OxyGo announced that they have acquired LIFE Corporation, a manufacturer of portable emergency oxygen and CPR administration equipment. The acquisition will allow OxyGo to further expand its expertise in the oxygen market.

Key Takeaways from the Medical Oxygen Concentrators Market Report Study

• Market size analysis for current Medical Oxygen Concentrators market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Medical Oxygen Concentrators market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Medical Oxygen Concentrators market.
• Various opportunities available for the other competitor in the Medical Oxygen Concentrators market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current Medical Oxygen Concentrators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Medical Oxygen Concentrators market growth in the coming future?

Target Audience who can be benefited from this Medical Oxygen Concentrators Market Report Study

• Medical Oxygen Concentrators products providers
• Research organizations and consulting companies
• Medical Oxygen Concentrators -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Medical Oxygen Concentrators
• Various End-users who want to know more about the Medical Oxygen Concentrators market and latest technological developments in the Medical Oxygen Concentrators market.

Frequently Asked Questions for Medical Oxygen Concentrators Market:

1. What are Medical Oxygen Concentrators?

Medical Oxygen Concentrators are medical devices that provides supplemental oxygen to the patients with breathing disorder. The device filter the surrounding air, compressing it to the required density and then deliver the purified medical grade oxygen. The device is equipped with special filters and sieve beds which helps to remove nitrogen from the air and deliver completely purified oxygen to the patient.

2. What is the market for Global Medical Oxygen Concentrators?

The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2024-2030).

3. What are the drivers for the Global Medical Oxygen Concentrators Market?

The Medical Oxygen Concentrators market is witnessing a positive market growth owing to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea and other respiratory illness, increased demand in geriatric and bedridden patients, and due to unexpected demand of medical oxygen concentrators during COVID-19 pandemic across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Medical Oxygen Concentrators Market?

Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical India, O2 Concepts, Teijin Aramid B.V, Supera Anesthesia Innovations, GCE Group, CAIRE Inc., OxyGo, Precision medical, Inc., GF HEALTH PRODUCTS, INC., Belluscura, Besco, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.

5. Which region has the highest share in Medical Oxygen Concentrators Market?

North America is expected to hold the highest share in the revenue in the Medical Oxygen Concentrators market during the forecast period. Factors such as the growing prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased demand in geriatric and bedridden patients are expected to aid in the growth of the North America Medical Oxygen Concentrators Market in this region.

Table of Contents

1.Medical Oxygen Concentrators Market Report Introduction

2.Medical Oxygen Concentrators Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Medical Oxygen Concentrators Market Key Factors Analysis

• 4.1. Medical Oxygen Concentrators Market Drivers
  • 4.1.1. Increased Need For Medical Oxygen Concentrators For Geriatric And Bedridden Patients
  • 4.1.2. Increased Prevalence Of Respiratory Illness
  • 4.1.3. Unexpected Demand Of Oxygen Concentrators During COVID-19 Pandemic
• 4.2. Medical Oxygen Concentrators Market Restraints and Challenges
  • 4.2.1. Strict Regulatory Approvals
  • 4.2.2. High Cost
• 4.3. Medical Oxygen Concentrators Market Opportunities
  • 4.3.1. Increase In Demand Of Portable Oxygen Concentrators
  • 4.3.2. Customization Of Flow Rate

5. Medical Oxygen Concentrators Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Medical Oxygen Concentrators Market

7. Medical Oxygen Concentrators Market Layout

• 7.1. By Product
  • 7.1.1. Stationary
  • 7.1.2. Portable
• 7.2. By Technology
  • 7.2.1. Continuous Flow
  • 7.2.2. Pulse Flow
  • 7.2.3. Both
• 7.3. By End User
  • 7.4.1. Homecare
  • 7.4.2. Hospitals and Clinics
  • 7.4.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Medical Oxygen Concentrators Market, by Country
    • 7.4.1.1.1. United States
    • 7.4.1.1.2. Canada
    • 7.4.1.1.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Medical Oxygen Concentrators Market, by Country
    • 7.4.2.1.1. France
    • 7.4.2.1.2. Germany
    • 7.4.2.1.3. United Kingdom
    • 7.4.2.1.4. Italy
    • 7.4.2.1.5. Spain
    • 7.4.2.1.6. Russia
    • 7.4.2.1.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Medical Oxygen Concentrators Market, by Country
    • 7.4.3.1.1. China
    • 7.4.3.1.2. Japan
    • 7.4.3.1.3. India
    • 7.4.3.1.4. Australia
    • 7.4.3.1.5. South Korea
    • 7.4.3.1.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Medical Oxygen Concentrators Market, by Region
    • 7.4.4.1.1. Middle East
    • 7.4.4.1.2. Africa
    • 7.4.4.1.3. South America

8. Medical Oxygen Concentrators Market Global Company Share Analysis - Key 3-5 Companies

9. Medical Oxygen Concentrators Market Company and Product Profiles

• 9.1. Koninklijke Philips N.V.
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Invacare Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. DeVilbiss Healthcare LLC
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Inogen, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Nidek Medical India
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. O2 Concepts
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Teijin Aramid B.V
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Supera Anesthesia Innovations
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. GCE Group
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. CAIRE Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. OxyGo
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Precision medical, Inc.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. GF HEALTH PRODUCTS, INC.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Belluscura
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Besco
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. OSI - Oxygen Solutions Inc
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. NGK Spark Plug Co Ltd
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Narang Medical Limited
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Topson
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us